Takeda Pharmaceutical Li...

PNK: TKPHF · Real-Time Price · USD
29.85
-2.28 (-7.10%)
At close: Apr 30, 2025, 3:48 PM

Takeda Pharmaceutical Statistics

Share Statistics

Takeda Pharmaceutical has 1.59B shares outstanding. The number of shares has increased by 1.03% in one year.

Shares Outstanding 1.59B
Shares Change (YoY) 1.03%
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating n/a
Failed to Deliver (FTD) Shares n/a
FTD / Avg. Volume n/a

Short Selling Information

The latest short interest is 1.87M, so 0.12% of the outstanding shares have been sold short.

Short Interest 1.87M
Short % of Shares Out 0.12%
Short % of Float 0.12%
Short Ratio (days to cover) 14.49

Valuation Ratios

The PE ratio is 45.96 and the forward PE ratio is null. Takeda Pharmaceutical's PEG ratio is -0.84.

PE Ratio 45.96
Forward PE n/a
PS Ratio 1.55
Forward PS n/a
PB Ratio 0.91
P/FCF Ratio 28.1
PEG Ratio -0.84
Financial Ratio History

Enterprise Valuation

Takeda Pharmaceutical has an Enterprise Value (EV) of 11,626.9B.

EV / Sales 2.73
EV / EBITDA 12.91
EV / EBIT 16.23
EV / FCF 49.35

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.75.

Current Ratio 1.11
Quick Ratio 0.58
Debt / Equity 0.75
Debt / EBITDA 6.07
Debt / FCF 23.19
Interest Coverage 1.79

Financial Efficiency

Return on Equity is 1.98% and Return on Invested Capital is 4.42%.

Return on Equity 1.98%
Return on Assets 0.95%
Return on Invested Capital 4.42%
Revenue Per Employee $86,519,388.81
Profits Per Employee $2,923,378.18
Employee Count 49,281
Asset Turnover 0.28
Inventory Turnover 1.18

Taxes

Income Tax -91.41B
Effective Tax Rate -173.15%

Stock Price Statistics

The stock price has increased by 12.13% in the last 52 weeks. The beta is 0.34, so Takeda Pharmaceutical's price volatility has been higher than the market average.

Beta 0.34
52-Week Price Change 12.13%
50-Day Moving Average 30.07
200-Day Moving Average 27.67
Relative Strength Index (RSI) 47.68
Average Volume (20 Days) 10,444

Income Statement

In the last 12 months, Takeda Pharmaceutical had revenue of 4,263.8B and earned 144.07B in profits. Earnings per share was 92.09.

Revenue 4,263.8B
Gross Profit 2,832.3B
Operating Income 214.07B
Net Income 144.07B
EBITDA 900.33B
EBIT 172.33B
Earnings Per Share (EPS) 92.09
Full Income Statement

Balance Sheet

The company has 457.8B in cash and 5,463.4B in debt, giving a net cash position of -5,005.6B.

Cash & Cash Equivalents 457.8B
Total Debt 5,463.4B
Net Cash -5,005.6B
Retained Earnings 1,391.2B
Total Assets 15,106.8B
Working Capital 656.32B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 716.34B and capital expenditures -480.73B, giving a free cash flow of 235.61B.

Operating Cash Flow 716.34B
Capital Expenditures -480.73B
Free Cash Flow 235.61B
FCF Per Share 150.61
Full Cash Flow Statement

Margins

Gross margin is 66.43%, with operating and profit margins of 5.02% and 3.38%.

Gross Margin 66.43%
Operating Margin 5.02%
Pretax Margin 1.24%
Profit Margin 3.38%
EBITDA Margin 21.12%
EBIT Margin 5.02%
FCF Margin 5.53%

Dividends & Yields

TKPHF pays an annual dividend of $1.95, which amounts to a dividend yield of 4.24%.

Dividend Per Share $1.95
Dividend Yield 4.24%
Dividend Growth (YoY) 5.11%
Payout Ratio 216.97%
Earnings Yield 2.18%
FCF Yield 3.56%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for TKPHF.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 0.55
Piotroski F-Score 6